MLN-4760

An experimental ACE2 inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
Supporting references
0
Contradictory references
10
AI-suggested references
0
Clinical trials

General information

MLN-4760 on PubChem


Synonyms

(S,S)-2-{1-Carboxy-2-[3-(3,5-dichloro-benzyl)-3H-imidazol-4-YL]-ethylamino}-4-methyl-pentanoic acid

 

Structure image - MLN-4760

CC(C)C[C@@H](C(=O)O)N[C@@H](CC1=CN=CN1CC2=CC(=CC(=C2)Cl)Cl)C(=O)O


Supporting references

Link Tested on Impact factor Notes Publication date
An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2
Spike protein ACE2 Small molecule In silico
in silico 2.86

Computationally modelled to impede SARS-CoV-2 Spike protein-host ACE2 receptor interaction.

Mar/03/2021

AI-suggested references